Abstract
The renaissance of 68Ga radiopharmacy has led to great advances in automation technology. The availability of a highly efficient, reliable, long-lived 68Ge/68Ga generator system along with a well-established coordination chemistry based on bifunctional chelating agents have been the bases of this development in 68Ga radiopharmacy. Syntheses of 68Ga peptides were originally performed by manual or semiautomated systems, but increasing clinical demand, radioprotection, and regulatory issues have driven extensive automation of their production process. Several automated systems, based on different post-processing of the 68Ga generator eluate, on different engineering, and on fixed tubing or disposable cassette approaches, have been developed and are discussed in this chapter. Since automatic systems for preparation of radiopharmaceuticals should comply with qualification and validation protocols established by regulations such as current Good Manufacturing Practices (cGMP) and local regulations, some regulatory issues and the more relevant qualification protocols are also discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bauwens M, Chekol R, Vanbilloen H et al (2010) Optimal buffer choice of the radiosynthesis of 68Ga-Dotatoc for clinical application. Nucl Med Biol 31(8):753–758
Breeman WAP, de Jong M, de Blois E et al (2005) Radiolabelling DOTA-peptide with 68Ga. Eur J Nucl Med 32:478–485
Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34(10):1617–1626
Campana D, Ambrosini V, Pezzilli R et al (2010) Standardized uptake values of 68Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J Nucl Med 51(3):353–359
Deutsch E (1993) Clinical PET: its time has come? J Nucl Med 34:1132–1133
Decristoforo C, Knopp R, Von Guggenberg E et al (2007) A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun 28(11):870–875
Di Pierro D, Rizzello A, Cicoria G et al (2008) Radiolabelling, quality control and radiochemical purity assessment of the octreotide analogue 68Ga DOTA NOC. Appl Radiat Isot 66:1091–1096
Fani M, Del Pozzo L, Abiraj K et al (2011) PET of somatostatin receptor-positive tumors using 64Cu and 68Ga somatostatin antagonists: the chelate makes the difference. J Nucl Med 52(7):1110–1118
GAMP® 5: A risk-based approach to compliant GxP computerized systems. ISPE 2008
Hayes RL, Carlton JE, Byrd BL (1965) Bone scaning with gallium-68: a carrier effect. J Nucl Med 6:605–610
Harris WR, Pecoraro V (1983) Thermodynamic binding constants for gallium transferrin. Biochemistry 22:292–299
Kowalski J, Henze M, Schuhmacher J et al (2003) Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D-Phe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 5:42–48
Maecke HR, Hofmann M, Haberkorn U (2005) 68Ga peptides in tumor imaging. J Nucl Med 46:172S–176S
Meyer GJ, Maecke H, Schuhmacher J et al (2004) 68Ga- labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31:1097–1104
Ocak M, Antretter M, Knopp R et al (2010) Full automation of 68 Ga labelling of DOTA-peptides including cation exchange prepurification. Appl Radiat Isot 68:297–302
Petrik M, Knetsch PA, Knopp R et al (2011) Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system. Nucl Med Commun 32(10):887–895
Roesch F, Riss PJ (2010) The reinassance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry. Curr Top Med Chem 10:1633–1668
Shealey CN, Aronow S, Brownell GL (1964) Gallium-68 as a scanning agents for intracranial lesions. J Nucl Med 5:161–167
Velikyan I, Beyer GJ, Langstrom B (2004) Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjugate Chem 15(3):554–560
Velikyan I, Maecke H, Langstrom B (2008) Convenient preparation of 68Ga-based PET radiopharmaceuticals at room temperature. Bioconjugate Chem 19:569–573
Zhernosekov KP, Filosofov DV, Baum RP et al (2007) Processing of generator-produced Ga-68 for medical application. J Nucl Med 48(10):1741–1748
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Boschi, S., Malizia, C., Lodi, F. (2013). Overview and Perspectives on Automation Strategies in 68Ga Radiopharmaceutical Preparations. In: Baum, R., Rösch, F. (eds) Theranostics, Gallium-68, and Other Radionuclides. Recent Results in Cancer Research, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27994-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27994-2_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27993-5
Online ISBN: 978-3-642-27994-2
eBook Packages: MedicineMedicine (R0)